| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965526 | Vaccine | 2015 | 11 Pages |
Abstract
Both investigational MenABCWY formulations elicited robust immune responses against serogroups ACWY and serogroup B test strains, and had acceptable reactogenicity profiles, with no safety concerns identified.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stan L. Block, Leszek Szenborn, Wendy Daly, Teresa Jackowska, Diego D'Agostino, Linda Han, Peter M. Dull, Igor Smolenov,